Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
Lead Product(s) : HYDROXYPROPYLMETHYLCELLULOSE,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Milton M. Hom
Deal Size : Inapplicable
Deal Type : Inapplicable
Tear Osmolarity Over Time With Artificial Tears
Details : HYDROXYPROPYLMETHYLCELLULOSE is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
October 25, 2010
Lead Product(s) : Hyaluronic Acid,HYDROXYPROPYLMETHYLCELLULOSE
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Allergan Aesthetics looks to further develop the Hybrid Injectables category by introducing its first dual-effect product, which combines the two active ingredients - hyaluronic acid, a well-known ingredient found in facial fillers and calcium hydroxyapa...
Product Name : Juvederm Volux XC
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 29, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
50
PharmaCompass offers a list of HYDROXYPROPYLMETHYLCELLULOSE API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier.
PharmaCompass also assists you with knowing the HYDROXYPROPYLMETHYLCELLULOSE API Price utilized in the formulation of products. HYDROXYPROPYLMETHYLCELLULOSE API Price is not always fixed or binding as the HYDROXYPROPYLMETHYLCELLULOSE Price is obtained through a variety of data sources. The HYDROXYPROPYLMETHYLCELLULOSE Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Durapatite manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Durapatite, including repackagers and relabelers. The FDA regulates Durapatite manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Durapatite API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Durapatite supplier is an individual or a company that provides Durapatite active pharmaceutical ingredient (API) or Durapatite finished formulations upon request. The Durapatite suppliers may include Durapatite API manufacturers, exporters, distributors and traders.
click here to find a list of Durapatite suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Durapatite DMF (Drug Master File) is a document detailing the whole manufacturing process of Durapatite active pharmaceutical ingredient (API) in detail. Different forms of Durapatite DMFs exist exist since differing nations have different regulations, such as Durapatite USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Durapatite DMF submitted to regulatory agencies in the US is known as a USDMF. Durapatite USDMF includes data on Durapatite's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Durapatite USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Durapatite suppliers with USDMF on PharmaCompass.
A Durapatite CEP of the European Pharmacopoeia monograph is often referred to as a Durapatite Certificate of Suitability (COS). The purpose of a Durapatite CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Durapatite EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Durapatite to their clients by showing that a Durapatite CEP has been issued for it. The manufacturer submits a Durapatite CEP (COS) as part of the market authorization procedure, and it takes on the role of a Durapatite CEP holder for the record. Additionally, the data presented in the Durapatite CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Durapatite DMF.
A Durapatite CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Durapatite CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Durapatite suppliers with CEP (COS) on PharmaCompass.
Durapatite Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Durapatite GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Durapatite GMP manufacturer or Durapatite GMP API supplier for your needs.
A Durapatite CoA (Certificate of Analysis) is a formal document that attests to Durapatite's compliance with Durapatite specifications and serves as a tool for batch-level quality control.
Durapatite CoA mostly includes findings from lab analyses of a specific batch. For each Durapatite CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Durapatite may be tested according to a variety of international standards, such as European Pharmacopoeia (Durapatite EP), Durapatite JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Durapatite USP).
